LACTIGA Approach
We are pioneering the development of novel biologics to prevent and treat infections. By keeping the focus on immunodeficient patients, we are developing therapies to treat unmet medical needs.
In addition to our ongoing research, the company has raised venture capital and non-dilutive grants to advance to IND filing.



© Lactiga
2023